We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
SEI Investments (SEIC) Lags on Q4 Earnings as Expenses Rise
Read MoreHide Full Article
SEI Investments Co.’s (SEIC - Free Report) fourth-quarter 2019 earnings of 84 cents per share lagged the Zacks Consensus Estimate of 86 cents. However, the figure reflects a rise of 15.1% from the prior-year quarter.
Results were hurt by a rise in expenses. However, growth in revenues and assets under management (AUM) were tailwinds.
Net income was $128.7 million, up 10.9% from the year-ago quarter.
For 2019, earnings per share were $3.24, which lagged the Zacks Consensus Estimate of $3.26. However, the figure reflects growth of 3.2% from the previous year. Net income for the year was $501.4 million, down marginally from that reported in 2018.
Revenues & AUM Improve, Expenses Rise
Total quarterly revenues were $423.2 million, up 4.5% year over year. The rise reflected higher asset management, administration and distribution fees. Moreover, the reported figure surpassed the Zacks Consensus Estimate of $422.5 million.
For 2019, total revenues were $1.65 billion, up 1.6% year over year. The rise reflected higher asset management, administration and distribution fees. The reported figure was in line with the Zacks Consensus Estimate.
Total quarterly expenses were $307.1 million, up 1.7% year over year. The rise was due to an increase in almost all components of expenses, except for software royalties and other information processing costs; compensation, benefits and other personnel expenses; and depreciation costs.
Operating income increased 12.8% year over year to $116.1 million.
As of Dec 31, 2019, AUM was $352 billion, reflecting a rise of 14.6% from the prior-year quarter. Client assets under administration (AUA) were $683.3 billion, up 19.4% year over year. Note that client AUA does not include $13.1 billion related to Funds of Funds assets that were reported on Dec 31, 2019.
Share Repurchase
In the reported quarter, SEI Investments bought back 1.3 million shares for $81.2 million.
Our Take
The company’s solid AUM balance, global presence, diversified product offerings and rising demand for SEI Wealth Platform (SWP) are expected to continue to aid financials. Also, its enhanced capital-deployment activities will likely continue to reward shareholders.
SEI Investments Company Price, Consensus and EPS Surprise
Performance & Release Date of Other Investment Managers
BlackRock, Inc.’s (BLK - Free Report) fourth-quarter 2019 adjusted earnings of $8.34 per share surpassed the Zacks Consensus Estimate of $7.67. Moreover, the figure was 37.2% higher than the year-ago quarter’s number.
Cohen & Steers’ (CNS - Free Report) fourth-quarter 2019 adjusted earnings of 74 cents per share surpassed the Zacks Consensus Estimate of 67 cents. Also, the bottom line was 32.1% higher than the year-ago quarter figure.
Affiliated Managers Group, Inc. (AMG - Free Report) is slated to announce results on Feb 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
SEI Investments (SEIC) Lags on Q4 Earnings as Expenses Rise
SEI Investments Co.’s (SEIC - Free Report) fourth-quarter 2019 earnings of 84 cents per share lagged the Zacks Consensus Estimate of 86 cents. However, the figure reflects a rise of 15.1% from the prior-year quarter.
Results were hurt by a rise in expenses. However, growth in revenues and assets under management (AUM) were tailwinds.
Net income was $128.7 million, up 10.9% from the year-ago quarter.
For 2019, earnings per share were $3.24, which lagged the Zacks Consensus Estimate of $3.26. However, the figure reflects growth of 3.2% from the previous year. Net income for the year was $501.4 million, down marginally from that reported in 2018.
Revenues & AUM Improve, Expenses Rise
Total quarterly revenues were $423.2 million, up 4.5% year over year. The rise reflected higher asset management, administration and distribution fees. Moreover, the reported figure surpassed the Zacks Consensus Estimate of $422.5 million.
For 2019, total revenues were $1.65 billion, up 1.6% year over year. The rise reflected higher asset management, administration and distribution fees. The reported figure was in line with the Zacks Consensus Estimate.
Total quarterly expenses were $307.1 million, up 1.7% year over year. The rise was due to an increase in almost all components of expenses, except for software royalties and other information processing costs; compensation, benefits and other personnel expenses; and depreciation costs.
Operating income increased 12.8% year over year to $116.1 million.
As of Dec 31, 2019, AUM was $352 billion, reflecting a rise of 14.6% from the prior-year quarter. Client assets under administration (AUA) were $683.3 billion, up 19.4% year over year. Note that client AUA does not include $13.1 billion related to Funds of Funds assets that were reported on Dec 31, 2019.
Share Repurchase
In the reported quarter, SEI Investments bought back 1.3 million shares for $81.2 million.
Our Take
The company’s solid AUM balance, global presence, diversified product offerings and rising demand for SEI Wealth Platform (SWP) are expected to continue to aid financials. Also, its enhanced capital-deployment activities will likely continue to reward shareholders.
SEI Investments Company Price, Consensus and EPS Surprise
SEI Investments Company price-consensus-eps-surprise-chart | SEI Investments Company Quote
Currently, SEI Investments sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Performance & Release Date of Other Investment Managers
BlackRock, Inc.’s (BLK - Free Report) fourth-quarter 2019 adjusted earnings of $8.34 per share surpassed the Zacks Consensus Estimate of $7.67. Moreover, the figure was 37.2% higher than the year-ago quarter’s number.
Cohen & Steers’ (CNS - Free Report) fourth-quarter 2019 adjusted earnings of 74 cents per share surpassed the Zacks Consensus Estimate of 67 cents. Also, the bottom line was 32.1% higher than the year-ago quarter figure.
Affiliated Managers Group, Inc. (AMG - Free Report) is slated to announce results on Feb 3.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>